IL17A and Anxiety: It is shown that after injecting IL-17a antibody into the mPFC of ASD model mice to neutralize IL-17a, the ASD mouse model reproduced the same therapeutic effect as using taVNS, which includes improved anxiety and social function, reduced number of microglia, and inhibited M1 polarization.